Dr Tom Turner is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. He has completed a PhD in Neuroscience at University College London (UCL) Queen Square Institute of Neurology, working in the labs of Professor Dimitri Kullmann and Dr Gabriele Lignani. Tom's research was funded by the Medical Research Council and explored the use of CRISPR genome editing as a treatment for genetic neurological diseases. Previously, he studied Pharmacology at UCL, with research experience in cellular signalling mechanisms at the University of Cambridge's Department of Pharmacology.
Using CRISPR to edit a single gene in mice with head and neck cancer led to half of them becoming tumour-free...
A molecule that can be used to enhance CRISPR genome editing also causes unintended destruction of large sections of the genome in human cells...
UK BioBank, and potentially other organisations, will be able to access the GP data of consenting participants in England...
Award-winning and prolific science writer, Dr Philip Ball, offers a wide perspective in his latest book 'How Life Works'...
An Israeli strike on the largest fertility clinic in Gaza has destroyed thousands of embryos...
Using research from both social sciences and genetics literature as support, Ancestry Reimagined establishes realistic expectations about what we can learn from our DNA and the impact of an increased access to ancestry testing...
Esther Perel's cult podcast explores how a complex web of lies has affected a sperm donor, his marriage and his family...
The first gene therapy for haemophilia A has been approved for severe cases by the US Food and Drug Administration...
CRISPR genome editing has been tested in feline cells on the genes that cause allergic reactions in humans, potentially paving the way to hypoallergenic cats...
Genetic variations that are associated with severe COVID-19 symptoms have been identified by sequencing the genomes of intensive care patients.
Join our list to stay up-to-date on all the latest developments in the fields of human fertility and genomics.
